Immunogenicity to infliximab is associated with HLA-DRB1.
Billiet T, Vande Casteele N, Van Stappen T, Princen F, Singh S, Gils A, Ferrante M, Van Assche G, Cleynen I, Vermeire S.
Billiet T, et al. Among authors: van stappen t, van assche g.
Gut. 2015 Aug;64(8):1344-5. doi: 10.1136/gutjnl-2015-309698. Epub 2015 Apr 15.
Gut. 2015.
PMID: 25876612
No abstract available.